𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case-control study

✍ Scribed by R.E. Hempling; C. Wong; M.S. Piver; N. Natarajan; C.J. Mettlin

Book ID
117532860
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
106 KB
Volume
28
Category
Article
ISSN
0378-5122

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A case-control study on hormone therapy
A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well
✍ Heli K. Lyytinen; Tadeusz Dyba; Olavi Ylikorkala; Eero I. Pukkala πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 124 KB πŸ‘ 1 views

## Abstract The purpose of this study was to evaluate the association between postmenopausal hormone therapy (HT) and the risk for breast cancer in recently postmenopausal Finnish women. All Finnish women with first invasive breast cancer diagnosed between the ages of 50 and 62 years during 1995–20

Hormone replacement therapy and cancer r
Hormone replacement therapy and cancer risk: A systematic analysis from a network of case-control studies
✍ Esteve Fernandez; Silvano Gallus; Cristina Bosetti; Silvia Franceschi; Eva Negri πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 2 views

## Abstract To provide comprehensive and quantitative information on the benefits and risks of hormone replacement therapy (HRT) on several cancer sites, we systematically examined the relation between HRT use and the risk of various cancers in women aged 45–79 by using data from a framework of cas